Under construction – not a live service
Sign in

NCT05606419Suspended

The Crohn's Disease Exclusion Diet With Early Dairy Introduction vs Partial Enteral Nutrition for Crohn's Disease

The Crohn's Disease Exclusion Diet With Early Dairy Introduction vs Partial Enteral Nutrition (CD-EDEN) in Adult Patients With Crohn's Disease

Source: ClinicalTrials.gov · Last updated 30 Sept 2025

Reason given: Study was suspended on September 24 because of funding constraints. At that point, approximately 50 % of the planned participants had enrolled. All data collected to date will be analyzed.

Brief summary (registry, in English)

This study aims to evaluate a novel diet for adult Crohn's disease patients (The Crohn's Disease Exclusion Diet - CDED). Some of the patients in this study will receive the CDED combined with partial enteral nutrition (PEN), while the other group will receive the CDED with early introduction of dairy products, that were eliminated from the initial CDED protocol.

Status (registry)
Suspended
Study type
Interventional
Enrollment
44 (estimated)
First submitted
24 Oct 2022
Start date
10 Mar 2024
Primary completion date
Jul 2026
Lead sponsor
Evangelismos Hospital
NCT number
NCT05606419

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous extensive bowel resection
  • Introduction of or change in dose of drug therapy within the past 8 weeks
  • Comorbidities including diabetes or coeliac disease, or other concomitant serious comorbidity e.g. significant psychiatric, hepatic, renal, endocrine, respiratory, neurological, cardiovascular, neoplastic or other autoimmune disease

Other illness

  • Food allergies or intolerances, which do not permit participation in the study
  • Any proven current infection such as positive stool cultures or positive tests for parasites or C. difficile. Stool tests are mandatory only if diarrhea is present.

Age

  • Age < 18 years old

Other

  • Reported pregnancy or lactation
  • Current stoma
  • Current abscess
  • Clinically significant stricture

Who the study is looking for

  • Participants must have an established diagnosis of CD
  • Participants must have clinically active disease defined as HBI ≥ 5
  • Participants must have confirmed inflammation at screening as CRP > 5 mg/L, FC >100 mg/g, or presence of inflammation on endoscopy in the 3 months before screening based on retrospective review of procedure reports by the local investigator and the clinician's assessment
  • Individuals able to give informed consent and willingness to participate

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Evangelismos General Hospital of AthensAthensGreeceUnknown status

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.